Science Explorer Back to mapMap
Discussion
Company · George Town · Malaysia

Sentinext Therapeutics (Malaysia)

sentinext.comROR OpenAlex
Research works
8
▼ 97% vs 2018-21
Citations
296
37.9 per fractional work
Top-10% rate
12.5%
all institutions 10.0%
Open access
51%
world 40%
International
55%
world 18%
Sentinext Therapeutics (Malaysia)

Not ranked overall: Sentinext Therapeutics (Malaysia) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Sentinext Therapeutics (Malaysia) work in?

In all years, 71% of research at Sentinext Therapeutics (Malaysia) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (69%), Agricultural and Biological Sciences (16%), Biochemistry, Genetics and Molecular Biology (9%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 71.3% of its workMedicine: 5 fractional works · 68.8% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 31.9% of its workInfectious Diseases: 1 fractional works · 18.4% of its workPathology and Forensic Medicine: 1 fractional works · 8.6% of its workEpidemiology: 0 fractional works · 4.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 4.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 2.2% of its workSmall Animals: 0 fractional works · 2.2% of its workHealth Professions: 0 fractional works · 0.4% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 25.5% of its workAgricultural and Biological Sciences: 1 fractional works · 16.3% of its workAgronomy and Crop Science: 1 fractional works · 10.6% of its workAnimal Science and Zoology: 0 fractional works · 4.2% of its workPlant Science: 0 fractional works · 1.4% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 9.2% of its workMolecular Biology: 1 fractional works · 7.8% of its workGenetics: 0 fractional works · 1.4% of its workSocial Sciences: 0 fractional works · 3.2% of its workDecision Sciences: 0 fractional works · 2.2% of its workStatistics, Probability and Uncertainty: 0 fractional works · 2.2% of its workSocial Sciences: 0 fractional works · 1.0% of its workSociology and Political Science: 0 fractional works · 1.0% of its workALL ITS WORKSentinextTherapeutics…8fractional works, all years
Life Sciences25%Health Sciences71%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine568.8%
    2. Veterinary02.2%
    3. Health Professions00.4%
    1. Agricultural and Biological Sciences116.3%
    2. Biochemistry, Genetics and Molecular Biology19.2%
    1. Decision Sciences02.2%
    2. Social Sciences01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Sentinext Therapeutics (Malaysia)?

The most cited paper from Sentinext Therapeutics (Malaysia) is "Crystal Structure of Human Enterovirus 71" (Pavel Plevka, Rushika M. Perera, Jane Cardosa et al., 2012), with 220 citations. Next come "Structure of human enterovirus 71 in complex with a capsid-binding inhibitor" (83) and "Neutralizing antibodies can initiate genome release from human enterovirus 71" (74).

Most cited papers
#PaperReleasedCitations
1 Crystal Structure of Human Enterovirus 71 Pavel Plevka, Rushika M. Perera, Jane Cardosa et al. · Science Open access 3 Mar 2012 220
2 Structure of human enterovirus 71 in complex with a capsid-binding inhibitor Pavel Plevka, Rushika M. Perera, Moh Lan Yap et al. · Proceedings of the National Academy of Sciences Open access 18 Mar 2013 83
3 Neutralizing antibodies can initiate genome release from human enterovirus 71 Pavel Plevka, Pei-Yin Lim, Rushika M. Perera et al. · Proceedings of the National Academy of Sciences Open access 27 Jan 2014 74
4 Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo Katherine I. Young, Stephanie Jane Mundis, Steven G. Widen et al. · Parasites & Vectors Open access 31 Aug 2017 56
5 Status of research and development of vaccines for enterovirus 71 Zarifah Hussain Reed, Mary Jane Cardosa · Vaccine Open access 11 Mar 2016 56
All 12 most cited papers, with filters and sorting

Which research topics does Sentinext Therapeutics (Malaysia) publish most on?

By volume in 2022-now: Homelessness and Social Issues, Cannabis and Cannabinoid Research and Prenatal Substance Exposure Effects.

  1. 1 Homelessness and Social Issues General Health Professions 0 works
  2. 2 Cannabis and Cannabinoid Research Pharmacology 0 works
  3. 3 Prenatal Substance Exposure Effects Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.2%not open48.8%

World: 40% of research is openly available.

with international co-authors55.2%domestic only44.8%

World: 18% is written across borders.

How has Sentinext Therapeutics (Malaysia)'s research output changed?

Output in 2022-2025 was 97% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in George Town

All research institutions in George Town

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sentinext Therapeutics (Malaysia). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.